Vera Therapeutics, Inc.
Recent Filings
All 433 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 27, 2026 |
| 4 | — | Mar 25, 2026 |
| 3 | — | Mar 25, 2026 |
| 4 | — | Mar 16, 2026 |
| SCHEDULE 13G | — | Mar 11, 2026 |
| 8-K | 8-K | Mar 9, 2026 |
| 4 | — | Mar 9, 2026 |
| 3 | — | Mar 9, 2026 |
| SCHEDULE 13D/A | — | Mar 5, 2026 |
| S-8 | S-8 | Feb 27, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Turner William D. | Chief Regulatory Officer | Sale | 10,000 @ $50.08 | 22,500 | Dec 15, 2025 |
| ENRIGHT PATRICK G | — | Purchase | 5,882 @ $42.50 | 5,882 | Dec 11, 2025 |
| Carter Jason S | Chief Legal Officer | Sale | 3,864 @ $27.82 | 49,136 | Nov 21, 2025 |
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Sale | 15,000 @ $29.06 | 47,839 | Nov 13, 2025 |
| ENRIGHT PATRICK G | — | Purchase | 139,595 @ $20.87 | 3,569,522 | Jun 23, 2025 |
| Fordyce Marshall | PRESIDENT AND CEO | Sale | 1,100 @ $28.32 | 204,665 | Feb 21, 2025 |
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Award / Grant | 10,740 | 61,946 | Feb 18, 2025 |
| Turner William D. | Chief Development Officer | Award / Grant | 22,500 | 22,500 | Feb 18, 2025 |
| Brenner Robert | Chief Medical Officer | Award / Grant | 26,900 | 27,474 | Feb 18, 2025 |
| Grant Sean | CHIEF FINANCIAL OFFICER | Award / Grant | 26,900 | 93,237 | Feb 18, 2025 |